Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2374-4677
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers ; volume:5 ; number:1 ; day:18 ; month:4 ; year:2019 ; pages:1-8 ; date:12.2019
npj Breast cancer ; 5, Heft 1 (18.4.2019), 1-8, 12.2019
- Creator
-
Groenendijk, Floris H.
Treece, Tina
Yoder, Erin
Baron, Paul
Beitsch, Peter
Audeh, William
Dinjens, Winand N. M.
Bernards, Rene
Whitworth, Pat
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41523-019-0109-7
- URN
-
urn:nbn:de:101:1-2019050406333645915641
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Groenendijk, Floris H.
- Treece, Tina
- Yoder, Erin
- Baron, Paul
- Beitsch, Peter
- Audeh, William
- Dinjens, Winand N. M.
- Bernards, Rene
- Whitworth, Pat
- SpringerLink (Online service)
Other Objects (12)
Manmade breast cancers
Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Surgery for Good Prognosis Breast Cancers
Surgery for Good Prognosis Breast Cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol
Manmade breast cancers
Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Surgery for Good Prognosis Breast Cancers
Surgery for Good Prognosis Breast Cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol
Manmade breast cancers
Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis
Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Estrogen receptor-α signaling in post-natal mammary development and breast cancers
Surgery for Good Prognosis Breast Cancers
Surgery for Good Prognosis Breast Cancers
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study